FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3135652267> ?p ?o ?g. }

• W3135652267 endingPage "107492" @default.
• W3135652267 startingPage "107492" @default.
• W3135652267 abstract "Empagliflozin is a SGLT2 inhibitor that reduces the concentration of blood glucose by inhibiting glucose reabsorption and promoting glucose excretion. Interestingly, empagliflozin also has some additional benefits, including cardiovascular protection, decreasing uric acid levels and improving NAFLD-related liver injury. However, the specific mechanism by which empagliflozin ameliorates NAFLD-related liver injury, especially how empagliflozin regulates hepatic immune inflammatory responses, is still unknown. In this study, male C57BL/6J mice were fed a high-fat diet and injected with streptozotocin to establish an animal model of T2DM with NAFLD. Then, diabetic mice with NAFLD were administered empagliflozin by gavage. We found that empagliflozin ameliorated liver injury and lipid metabolism disorder in T2DM mice with NAFLD. Empagliflozin significantly enhanced autophagy in hepatic macrophages via the AMPK/mTOR signalling pathway. After blocking autophagy and AMPK activity, empagliflozin could not prevent NAFLD-related liver injury. Furthermore, the expression levels of IL-17/IL-23 axis-related molecules were inhibited by empagliflozin through enhancing macrophage autophagy. Inhibition of IL-17/IL-23 axis activity attenuated liver injury in T2DM mice with NAFLD. In summary, these results suggested that empagliflozin could significantly ameliorate NAFLD-related liver injury, through enhancing hepatic macrophage autophagy via the AMPK/mTOR signalling pathway and further inhibiting IL-17/IL-23 axis-mediated inflammatory responses. This study provides a theoretical basis for the rational application of empagliflozin to treat T2DM with NAFLD and improve the quality of life of T2DM patients with NAFLD, which will have social benefits." @default.
• W3135652267 created "2021-03-15" @default.
• W3135652267 creator A5010484591 @default.
• W3135652267 creator A5013734131 @default.
• W3135652267 creator A5033998172 @default.
• W3135652267 creator A5040113499 @default.
• W3135652267 creator A5044470622 @default.
• W3135652267 creator A5050921331 @default.
• W3135652267 creator A5061817335 @default.
• W3135652267 creator A5078026673 @default.
• W3135652267 date "2021-05-01" @default.
• W3135652267 modified "2023-10-11" @default.
• W3135652267 title "The SGLT2 inhibitor empagliflozin negatively regulates IL-17/IL-23 axis-mediated inflammatory responses in T2DM with NAFLD via the AMPK/mTOR/autophagy pathway" @default.
• W3135652267 cites W1488772574 @default.
• W3135652267 cites W1954209695 @default.
• W3135652267 cites W1992523266 @default.
• W3135652267 cites W1993458861 @default.
• W3135652267 cites W2003512093 @default.
• W3135652267 cites W2007505836 @default.
• W3135652267 cites W2009868429 @default.
• W3135652267 cites W2013563454 @default.
• W3135652267 cites W2014750930 @default.
• W3135652267 cites W2020744745 @default.
• W3135652267 cites W2040126676 @default.
• W3135652267 cites W2044274736 @default.
• W3135652267 cites W2047642636 @default.
• W3135652267 cites W2059831042 @default.
• W3135652267 cites W2093897672 @default.
• W3135652267 cites W2101085816 @default.
• W3135652267 cites W2109666345 @default.
• W3135652267 cites W2112866067 @default.
• W3135652267 cites W2113507924 @default.
• W3135652267 cites W2117213923 @default.
• W3135652267 cites W2146264128 @default.
• W3135652267 cites W2160416763 @default.
• W3135652267 cites W2161883681 @default.
• W3135652267 cites W2171432910 @default.
• W3135652267 cites W2222894597 @default.
• W3135652267 cites W2273304042 @default.
• W3135652267 cites W2601655543 @default.
• W3135652267 cites W2696298149 @default.
• W3135652267 cites W2749591576 @default.
• W3135652267 cites W2774267942 @default.
• W3135652267 cites W2777514005 @default.
• W3135652267 cites W2783813405 @default.
• W3135652267 cites W2793289663 @default.
• W3135652267 cites W2808615577 @default.
• W3135652267 cites W2887583392 @default.
• W3135652267 cites W4250725029 @default.
• W3135652267 cites W90736706 @default.
• W3135652267 doi "https://doi.org/10.1016/j.intimp.2021.107492" @default.
• W3135652267 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33647823" @default.
• W3135652267 hasPublicationYear "2021" @default.
• W3135652267 type Work @default.
• W3135652267 sameAs 3135652267 @default.
• W3135652267 citedByCount "38" @default.
• W3135652267 countsByYear W31356522672021 @default.
• W3135652267 countsByYear W31356522672022 @default.
• W3135652267 countsByYear W31356522672023 @default.
• W3135652267 crossrefType "journal-article" @default.
• W3135652267 hasAuthorship W3135652267A5010484591 @default.
• W3135652267 hasAuthorship W3135652267A5013734131 @default.
• W3135652267 hasAuthorship W3135652267A5033998172 @default.
• W3135652267 hasAuthorship W3135652267A5040113499 @default.
• W3135652267 hasAuthorship W3135652267A5044470622 @default.
• W3135652267 hasAuthorship W3135652267A5050921331 @default.
• W3135652267 hasAuthorship W3135652267A5061817335 @default.
• W3135652267 hasAuthorship W3135652267A5078026673 @default.
• W3135652267 hasConcept C126322002 @default.
• W3135652267 hasConcept C134018914 @default.
• W3135652267 hasConcept C184235292 @default.
• W3135652267 hasConcept C185592680 @default.
• W3135652267 hasConcept C190283241 @default.
• W3135652267 hasConcept C203522944 @default.
• W3135652267 hasConcept C2775887513 @default.
• W3135652267 hasConcept C2776637226 @default.
• W3135652267 hasConcept C2777180221 @default.
• W3135652267 hasConcept C2780124434 @default.
• W3135652267 hasConcept C55493867 @default.
• W3135652267 hasConcept C555293320 @default.
• W3135652267 hasConcept C71924100 @default.
• W3135652267 hasConcept C86554907 @default.
• W3135652267 hasConcept C97029542 @default.
• W3135652267 hasConcept C98274493 @default.
• W3135652267 hasConceptScore W3135652267C126322002 @default.
• W3135652267 hasConceptScore W3135652267C134018914 @default.
• W3135652267 hasConceptScore W3135652267C184235292 @default.
• W3135652267 hasConceptScore W3135652267C185592680 @default.
• W3135652267 hasConceptScore W3135652267C190283241 @default.
• W3135652267 hasConceptScore W3135652267C203522944 @default.
• W3135652267 hasConceptScore W3135652267C2775887513 @default.
• W3135652267 hasConceptScore W3135652267C2776637226 @default.
• W3135652267 hasConceptScore W3135652267C2777180221 @default.
• W3135652267 hasConceptScore W3135652267C2780124434 @default.
• W3135652267 hasConceptScore W3135652267C55493867 @default.
• W3135652267 hasConceptScore W3135652267C555293320 @default.
• W3135652267 hasConceptScore W3135652267C71924100 @default.
• W3135652267 hasConceptScore W3135652267C86554907 @default.

• next